ReviewCurrent oncology reports2022

Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside.

Maria João de Sousa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.